The report provides a detailed analysis essential for establishing a Cabazitaxel production plant. It encompasses all critical aspects necessary for Cabazitaxel production, including the cost of Cabazitaxel production, Cabazitaxel plant cost, Cabazitaxel production costs, and the overall Cabazitaxel production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cabazitaxel production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cabazitaxel is a chemotherapy drug used to treat advanced prostate cancer that has spread to other parts of the body and no longer responds to hormone therapy or docetaxel chemotherapy. It is given in combination with a steroid medication called prednisone. It is a second-generation semisynthetic microtubule inhibitor that stabilizes microtubules. It also acts as an antineoplastic medication causing tumor death. It is synthesized from 10-deacetylbaccatin III, a substance that has been separated from yew trees.
The procurement of Cabazitaxel is influenced by its application in the pharmaceutical and medical industries as a chemotherapy drug used to treat advanced prostate cancer. The demand for Cabazitaxel is also increasing due to the rising cases of prostate cancer. Prostate cancer is the most frequent malignancy in males, which also happens to be the second largest cause of mortality from cancer in men, thus promoting the demand for drugs like Cabazitaxel.
It is given in combination with a steroid medication called Prednisone. It can also be utilized in combination with Prednisolone. Clinical trial results also showed that it is useful in increasing the overall survival rate in patients with prostate cancer, which enhances its demand. Overall, the industrial Cabazitaxel procurement is influenced by its application in the pharmaceutical and medical industries, combination therapy, clinical trial success rate, efficacy, rising cases of prostate cancer, healthcare awareness, technological advancements, cost and pricing, and regulatory approvals.
Raw Material for Cabazitaxel Production
According to the Cabazitaxel production plant project report, the key raw material used in the production of Cabazitaxel includes 10-deacetylbaccatin III.
Production Process of Cabazitaxel
The extensive Cabazitaxel production cost report consists of the following major industrial production process:
- Production from 10-deacetylbaccatin III: The production process of Cabazitaxel starts with the hydroxy protection of 10-deacetylbaccatin III with 2,2,2-trichloroethyl chloroformate to form the 7,10-di-Troc compound, which is subsequently nucleophilically substituted with ((chloromethoxy)methyl)benzene by N,N-diisopropylethylamine (DIPEA) promoted nucleophilic substitution, resulting in O-BOM (benzyloxymethyl). After being treated with Zn power, the compound experiences the elimination of Troc, resulting in an intermediate. The intermediate is subjected to alkaline conditions with methyl iodide to form an ether intermediate. O-deprotection in acid then produces the alcohol intermediate. Subsequently, an ester compound is produced by condensation of the alcohol intermediate with carboxylic acid compound and ring-opening in acid to produce Cabazitaxel.
Cabazitaxel, commercially known as Jevtana, is a yellow to brown-yellow viscous solution, having the molecular formula C45H57NO14 and a molecular weight of 835.9 g/mol. It has a melting point of around 170 °C. It has a water solubility of 0.00413 mg/mL. Its log P value is 3.69, and the value of its dissociation constant, pKa, is 11.96. Cabazitaxel is derived from 10-deacetylbaccatin III, a substance that has been separated from yew trees. It is a second-generation semisynthetic microtubule inhibitor that functions in stabilizing microtubules and causes tumor cell death.
